News
Portfolio Company News
- January 16, 2013
Astex Pharmaceuticals, Inc. - Cancer Research UK and Cancer Research Technology Initiate AT13148 Clinical Trial to
Treat Several Cancer Types
- January 08, 2013
First Subject Enrolled in OPUS-2, SARcode Bioscience’s Second Pivotal Study of Lifitegrast Ophthalmic Solution
- January 08, 2013
Vertiflex®, Inc. Announces FDA Clearance of Two Key Additions to Technology Portfolio
- January 07, 2013
ChemoCentryx Advances a New Generation CCR9 Inhibitor, CCX507, Into Clinical Development
- January 07, 2013
MacroGenics and Gilead Sciences Enter Strategic Alliance to Develop and Commercialize Four DART™ Products
- January 07, 2013
Esperion Announces Positive Topline Results from a Phase II Clinical Trial of ETC-1002 in Patients with Type 2 Diabetes
- January 03, 2013
Sutro Biopharma to Collaborate with Sanofi Pasteur on a Novel Production Approach for Vaccine Candidates
- January 03, 2013
Veloxis’ Phase 3 Trial of LCP-Tacro™ in Stable Kidney Transplant Patients, the 3001 Study, Published Online in the American Journal of Transplantation
- January 02, 2013
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients
- December 18, 2012
Sutro Biopharma Collaborates with Celgene Corporation to Design and Develop Next-Generation Antibody Drug Conjugates and
Bispecific Antibodies
- December 17, 2012
Medical Device Daily: Insulet Takes Insulin Delivery to Another Level with OmniPod - December 14, 2012
AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab® PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City
- December 10, 2012
Astex Pharmaceuticals Announces Results From Dose Escalation Part of SGI-110 Phase 1/2
MDS and AML Study in an Oral Presentation at ASH
- December 10, 2012
Portola Initiates Phase 2 Study of PRT4445,
Universal Antidote for Factor Xa Inhibitor Anticoagulants
- December 06, 2012
Veloxis Announces Preliminary Analysis of the STRATO Study Suggesting Reduction in Tremor in Kidney Transplant Patients Switched from Twice-Daily Tacrolimus to Once-Daily LCP-Tacro™
- November 29, 2012
Cytokinetics Announces Opening of Third and Final Cohort in ATOMIC-AHF
- November 27, 2012
ChemoCentryx Expands CCR2 Inhibitor Franchise with CCX872
- November 21, 2012
Ablynx and Algeta Enter Into A Research Collaboration to Evaluate the Potential of Novel Alpha-Pharmaceuticals Comprising
Thorium-277 Conjugated to Tumour-Targeting Nanobodies
- November 20, 2012
Kiadis Pharma Raises EUR 10 Million in Financing Round
- November 20, 2012
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2
MDS and AML Study at ASH
< Previous | Next >
